This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Helmholtz-Zentrum Dresden-Rossendorf E.v., Rotop Pharmaka Gmbh. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: The Innovations of Rodrigo Teodoro
Introduction
Rodrigo Teodoro is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of chemistry, particularly in the development of innovative compounds. His work has led to the creation of a unique patent that showcases his expertise and creativity.
Latest Patents
Rodrigo Teodoro holds a patent for a compound titled "Deuterated 7-(3-(4-(2-([18F]fluoro)ethoxy)phenyl)propyl)-2-(furan-2-yl)-7H-pyrazolo [4,3-e][1,2,4]triazolo[1,5-C]pyrimidine-5-amine derivatives." This compound is characterized by a general formula where residues X can be either hydrogen or deuterium, with the stipulation that at least one residue must be deuterium. This innovation reflects his commitment to advancing chemical research.
Career Highlights
Throughout his career, Rodrigo has worked with esteemed organizations such as Helmholtz-Zentrum Dresden-Rossendorf e.V. and Rotop Pharmaka GmbH. His experience in these institutions has allowed him to refine his skills and contribute to various research projects.
Collaborations
Rodrigo has collaborated with talented individuals in his field, including Rares-Petru Moldovan and Magali Toussaint. These partnerships have fostered a collaborative environment that enhances the quality of their research and innovations.
Conclusion
Rodrigo Teodoro is a distinguished inventor whose work in the field of chemistry has led to valuable innovations. His patent and collaborations highlight his dedication to advancing scientific knowledge and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile